Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
3-O-β-D-xylopyranosyl-(1-3)-β-D-glucuronopyranosyl-medicagenic acid 28-O-β-D-xylcopyranosyl-(1-4)-a-L-rhamnopyranosyl-(1 -2)-β-D-fucopyranosyl ester
3-O-β-D-xylopyranosyl-(1-3)-β-D-glucuronopyranosyl-medicagenic acid 28-O-β-D-xylcopyranosyl-(1-4)-a-L-rhamnopyranosyl-(1 -2)-β-D-fucopyranosyl ester
CAS No. ———
3-O-β-D-xylopyranosyl-(1-3)-β-D-glucuronopyranosyl-medicagenic acid 28-O-β-D-xylcopyranosyl-(1-4)-a-L-rhamnopyranosyl-(1 -2)-β-D-fucopyranosyl ester( ——— )
Catalog No. M38587 CAS No. ———
3-O-β-D-xylopyranosyl-(1→3)-β-D-glucuronopyranosyl-medicagenic acid 28-O-β-D-xylcopyranosyl-(1→4)-a-L-rhamnopyranosyl-(1 →2)-β-D-fucopyranosyl ester
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name3-O-β-D-xylopyranosyl-(1-3)-β-D-glucuronopyranosyl-medicagenic acid 28-O-β-D-xylcopyranosyl-(1-4)-a-L-rhamnopyranosyl-(1 -2)-β-D-fucopyranosyl ester
-
NoteResearch use only, not for human use.
-
Brief Description3-O-β-D-xylopyranosyl-(1→3)-β-D-glucuronopyranosyl-medicagenic acid 28-O-β-D-xylcopyranosyl-(1→4)-a-L-rhamnopyranosyl-(1 →2)-β-D-fucopyranosyl ester
-
Description3-O-β-D-xylopyranosyl-(1→3)-β-D-glucuronopyranosyl-medicagenic acid 28-O-β-D-xylcopyranosyl-(1→4)-a-L-rhamnopyranosyl-(1 →2)-β-D-fucopyranosyl ester
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Cannabisin B
Cannabisin B possesses considerable antiproliferative activity and that it may be utilised as a promising chemopreventive agent against hepatoblastoma disease.
-
NAV-2729
NAV-2729 inhibits six ArfGEFs (human ARNO, EFA6, BIG1, and BRAG2 and Legionella and Rickettsia RalF), the strongest effects being against BRAG2, Arf1 and Arf6.
-
2,3-Dehydrosilychris...
2,3-Dehydrosilychristin might have a biologically relevant inhibitory effect on ADH and glutamate dehydrogenase.
